Literature DB >> 9477105

Invasion of the bladder by transitional cell carcinoma: its relation to histologic grade and expression of p53, MIB-1, c-erb B-2, epidermal growth factor receptor, and bcl-2.

R T Vollmer1, P A Humphrey, P E Swanson, M R Wick, M L Hudson.   

Abstract

BACKGROUND: Although pathologic level of invasion and histologic grade are helpful in predicting the clinical outcome of transitional cell carcinoma of the bladder, they also create uncertainty. Immunohistochemical staining for p53, MIB-1, epidermal growth factor receptor (EGFR), c-erb B-2, and bcl-2 have shown promise as prognostic factors when evaluated singly, although multivariate analyses that include histologic grade and the interactive effects of these markers have not been studied extensively. The authors have initiated a prospective study to determine whether these markers add prognostic information to that provided by level of invasion and histologic grade. This initial report details how these five markers relate to invasion of the bladder after controlling for the effects of histologic grade.
METHODS: The authors evaluated 229 transitional cell carcinomas in 229 patients using the World Health Organization grading schema and immunohistochemical staining with antigen retrieval for p53, MIB-1, EGFR, c-erb B-2, and bcl-2, and they related these markers to invasion after controlling for grade with a multivariate logistic regression model.
RESULTS: Although Grades 2 and 3 were the most important for predicting invasion, Grade 2 tumors that stained for either MIB-1 or p53 indicated a significantly greater probability of invasion than suggested by grade alone. bcl-2 and p53 had an opposing and interactive effect: when p53 was absent, the presence of bcl-2 implied less probability of invasion; but when both bcl-2 and p53 were present, the protective effect of bcl-2 was no longer observed. Although neither EGFR nor c-erb B-2 were as important as the other three markers in determining the risk of invasion, Grade 3 tumors that stained for one, and especially both, of these markers were less likely to be invasive.
CONCLUSIONS: These five markers sort into three interactive pairs: MIB-1 and p53, bcl-2 and p53, and EGFR and c-erb B-2. MIB-1 and p53 together imply a greater probability of invasion. bcl-2 appears to have a dual role, which depends on the presence of accumulated p53. Finally, EGFR and c-erb B-2 related closely to each other and in Grade 3 tumors imply a lesser probability of invasion. It is likely that combinations of markers, or correlations between markers and grades, will yield prognostic information that is more powerful than what histologic grade alone can provide.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9477105     DOI: 10.1002/(sici)1097-0142(19980215)82:4<715::aid-cncr15>3.0.co;2-0

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  Assessment of differential gene expression patterns in human colon cancers.

Authors:  A Hernandez; F Smith; Q Wang; X Wang; B M Evers
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

Review 2.  Role of anti-Her-2 therapy in bladder carcinoma.

Authors:  Alvaro Pinto Marín; Enrique Espinosa Arranz; Andrés Redondo Sánchez; Pilar Zamora Auñón; Manuel González Barón
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-06       Impact factor: 4.553

3.  Urothelial carcinomas: a focus on human epidermal receptors signaling.

Authors:  Petros D Grivas; Mark Day; Maha Hussain
Journal:  Am J Transl Res       Date:  2011-07-25       Impact factor: 4.060

4.  The significance of p53 and bcl-2 overexpression and other prognostic factors in transitional cell carcinoma of the bladder.

Authors:  Stavros Touloupidis; Georgios Fatles; Christos Kalaitzis; Alexandra Giatromanolaki; Eythimyos Sivridis; Konstantinos Simopoulos; Vassilios Rombis
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

Review 5.  Chemotherapy in advanced bladder cancer: current status and future.

Authors:  Nabil Ismaili; Mounia Amzerin; Aude Flechon
Journal:  J Hematol Oncol       Date:  2011-09-09       Impact factor: 17.388

6.  Over-expression of HER-2 is associated with the stage in carcinomas of the urinary bladder.

Authors:  Khaled El Gehani; Lamia Al-Kikhia; Fatma Emaetig; Kari Syrjänen; Omran Al-Fituri; Adam Elzagheid
Journal:  Libyan J Med       Date:  2012-03-08       Impact factor: 1.657

7.  Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients.

Authors:  A A Memon; B S Sorensen; P Melgard; L Fokdal; T Thykjaer; E Nexo
Journal:  Br J Cancer       Date:  2004-12-13       Impact factor: 7.640

8.  Targeted therapies in the management of metastatic bladder cancer.

Authors:  Matteo Fassan; Edouard J Trabulsi; Leonard G Gomella; Raffaele Baffa
Journal:  Biologics       Date:  2007-12

9.  Fibroblast Growth Factor Receptor 1 Overexpression Is Associated with Poor Survival in Patients with Resected Muscle Invasive Urothelial Carcinoma.

Authors:  Seungtaek Lim; Myoung Ju Koh; Hyeon Joo Jeong; Nam Hoon Cho; Young Deuk Choi; Do Yeun Cho; Hoi Young Lee; Sun Young Rha
Journal:  Yonsei Med J       Date:  2016-07       Impact factor: 2.759

10.  Human epidermal growth factor receptor 2/neu overexpression in urothelial carcinoma of the bladder and its prognostic significance: Is it worth hype?

Authors:  Santosh Kumar; Omprakash Prajapati; Kim Vaiphei; Kalpesh Mahesh Parmar; A S Sriharsha; S K Singh
Journal:  South Asian J Cancer       Date:  2015 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.